Peter McCann, Civeo Corp's senior vice president for Australia, sold 4,000 common shares of the company on March 6, 2026, at a weighted average price of $28.64, producing proceeds of $114,560. The individual transaction prices within that block ranged from $28.59 to $28.90, according to the filing.
The disposition took place while Civeo's stock traded near its 52-week high of $29.68, with the share price having returned approximately 27% year-to-date. After the sale, McCann directly holds 50,942 common shares of Civeo.
Separately, an InvestingPro analysis referenced in the filing indicates that CVEO appears undervalued at current levels. Investors seeking additional data are directed to the Pro Research Report, which the notice states is available for CVEO and more than 1,400 other U.S. equities.
Recent company results provide context to the insider transaction. In the fourth quarter of 2025, Civeo reported a net loss per share of $0.56, wider than analyst forecasts projecting a $0.43 loss per share. Revenue for the quarter totaled $161.6 million, below the consensus expectation of $169.64 million.
Despite those shortfalls, the company recorded year-over-year revenue growth and improved EBITDA, which the report attributes to the firm's cost reduction initiatives. In light of the quarter and the 2026 outlook, Stifel raised its price target on Civeo to $37 from $33 and maintained a Buy rating, citing solid results and guidance that align with the firm's projections. Stifel also noted that Civeo continues to allocate free cash flow toward share repurchases.
This combination of an insider sale, a recent earnings miss, revenue shortfall versus expectations, and analyst support paints a mixed operational and market picture for investors following CVEO. The filing records and the company's reported financials are the primary, verifiable details available in the public disclosures referenced here.